HEPATITIS B IMMUNE GLOBULIN (HBIG) EFFICACY IN THE INTERRUPTION OF PERINATAL TRANSMISSION OF HEPATITIS B VIRUS CARRIER STATE
โ Scribed by Palmer Beasley, R.; Lin, Chia-Chin; Wang, Kwei-Yu; Hsieh, Fon-Jou; Hwang, Lu-Yu; Stevens, CladdE.; Sun, Tsu-Shen; Szmuness, Wolf
- Book ID
- 121798152
- Publisher
- The Lancet
- Year
- 1981
- Tongue
- English
- Weight
- 823 KB
- Volume
- 318
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
One hundred eleven newborn infants born of Spanish hepatitis B surface antigen (HBsAg) carrier mothers were consecutively assigned to one of three treatment groups. Group A was treated with three or four doses of hepatitis B immune globulin (HBIG) in one of three different schedules. Group B receive
A randomized double-blind, placebo-controlled efficacy trial of hepatitis B immune globulin (HBIG) for prevention of the mother-to-infant transmitted HBsAg carrier state was conducted in Taiwan where the carrier rate in the general population is 15 to 20%. HBIG was given immediately after birth to i